Page last updated: 2024-11-02

phenylbutazone and Ductus Arteriosus, Patent

phenylbutazone has been researched along with Ductus Arteriosus, Patent in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Renton, CP1

Other Studies

1 other study available for phenylbutazone and Ductus Arteriosus, Patent

ArticleYear
Patent ductus arteriosus.
    The Veterinary record, 1989, Oct-21, Volume: 125, Issue:17

    Topics: Animals; Cattle; Cattle Diseases; Drug Therapy, Combination; Ductus Arteriosus, Patent; Phenylbutazo

1989